Theratechnologies, Inc.
(Toronto Stock Exchange : THTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.76%53.580.9%$1397.83m
JNJJohnson & Johnson -0.07%179.330.7%$1294.93m
BMYBristol-Myers Squibb Co. -2.38%75.751.0%$1183.42m
MRKMerck & Co., Inc. 0.03%92.340.7%$1167.28m
ABBVAbbVie, Inc. -1.30%148.621.9%$1086.12m
LLYEli Lilly & Co. 1.53%318.251.1%$982.00m
AZNAstraZeneca Plc 0.67%67.151.0%$494.82m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.15%143.390.0%$493.30m
NVSNovartis AG -0.16%91.110.2%$259.42m
GSKGlaxoSmithKline Plc -1.02%43.970.2%$254.98m
VERUVeru, Inc. -1.13%12.500.0%$250.90m
HZNPHorizon Therapeutics Plc 3.71%93.955.4%$203.30m
SGENSeagen Inc. 2.88%142.455.7%$191.02m
NVONovo Nordisk A/S 0.63%107.270.1%$184.01m
VTRSViatris, Inc. 1.29%12.170.0%$167.47m

Company Profile

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.